January 13, 2010 - Whole brain radiotherapy (WBRT) is often recommended for patients with advanced cancer to receive quick access to palliative radiotherapy.

A recent study published in the International Journal of Radiation Oncology Biology Physics found that physicians referring patients with brain metastases for consideration of WBRT are often overly optimistic when estimating the clinical benefit of the treatment and overestimate patient survival.

The primary objective of the study was to determine what are physician’s expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy (WBRT). As a secondary objective, researchers were trying to understand what factors influence the expectations and to determine the accuracy of the physician-estimated patient survival.

Of the nearly 80 referring physicians surveyed, more than 94.9 percent said they believed WBRT would stabilize neurologic symptoms, improve quality of life, and allow for a Decadron (dexamethasone) taper; 87.0 percent said WBRT would improve performance status; 77.9 percent expected it to improve neurologic symptoms; and 40.8 percent thought it would improve survival. While the actual survival patient survival was a median of two and a half months, the referring physicians estimated patient survival rates would reach six months on average. This discrepancy represented a median individual difference of 1.9 months.

This led researchers to conclude referring physicians’ expectations of WBRT outcomes are often overly optimistic, the physicians tend to over estimate patient survival, and more education and research in this field is needed.

Reference: Barnes, EA; Chow, E; Tsao, MN; Bradley, NM; Doyle, M; Li, K; Lam, K; Danjoux, C. Physician Expectations of Treatment Outcomes for Patients With Brain Metastases Referred for Whole Brain Radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):187-192.


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now